Sanofi Ups Immuno-oncology Investment with US$2.5 B Synthorx Buy
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 12 (Table of Contents)
Published: 11 Dec-2019
DOI: 10.3833/pdr.v2019.i12.2476 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Reinforcing its interest in immuno-oncology, Sanofi has agreed to acquire US biotech, Synthorx, for US$2...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS